Cg Oncology Inc (NASDAQ: CGON) on Tuesday, plunged -6.65% from the previous trading day, before settling in for the closing price of $26.78. Within the past 52 weeks, CGON’s price has moved between $25.77 and $47.78.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -45.67% annually for the last half of the decade. The company achieved an average annual earnings per share of -13.72%. With a float of $40.60 million, this company’s outstanding shares have now reached $67.54 million.
In an organization with 61 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 97.81%, operating margin of -13969.15%, and the pretax margin is -10578.22%.
Cg Oncology Inc (CGON) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cg Oncology Inc is 39.96%, while institutional ownership is 75.68%. The most recent insider transaction that took place on Feb 18 ’25, was worth 28,610. In this transaction Director of this company sold 1,000 shares at a rate of $28.61, taking the stock ownership to the 0 shares. Before that another transaction happened on Jan 13 ’25, when Company’s Director sold 1,000 for $29.66, making the entire transaction worth $29,660. This insider now owns 0 shares in total.
Cg Oncology Inc (CGON) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -13.72% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
Cg Oncology Inc (CGON) is currently performing well based on its current performance indicators. A quick ratio of 35.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2798.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.28, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.76 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Let’s dig in a bit further. During the last 5-days, its volume was 0.48 million. That was inferior than the volume of 0.56 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.43%. Additionally, its Average True Range was 1.43.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 4.98%, which indicates a significant decrease from 12.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.65% in the past 14 days, which was lower than the 46.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.12, while its 200-day Moving Average is $33.20. However, in the short run, Cg Oncology Inc’s stock first resistance to watch stands at $27.13. Second resistance stands at $29.26. The third major resistance level sits at $30.73. If the price goes on to break the first support level at $23.53, it is likely to go to the next support level at $22.06. The third support level lies at $19.93 if the price breaches the second support level.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
Market capitalization of the company is 1.90 billion based on 76,038K outstanding shares. Right now, sales total 200 K and income totals -48,610 K. The company made 40 K in profit during its latest quarter, and -20,410 K in sales during its previous quarter.
